鼻咽癌放疗后甲状腺功能减退风险:人群队列研究
基于台湾健康保险数据库2000-2011年数据,纳入14,893例鼻咽癌放疗患者与16,105例其他头颈癌放疗患者,采用竞争风险回归分析。鼻咽癌患者放疗后需甲状腺素治疗的甲减风险显著高于匹配队列(aHR=14.35)和其他头颈癌队列(aHR=2.06)。年轻、女性、高城市化、自身免疫病和化疗是独立危险因素。
要点
- 鼻咽癌放疗后甲减风险显著高于一般人群和其他头颈癌患者。
- 年轻、女性、高城市化、自身免疫病及化疗是独立危险因素。
- 鼻咽癌幸存者放疗后应定期进行临床和血清甲状腺功能检测。
核心结论
- 鼻咽癌患者放疗后需甲状腺素治疗的甲减风险显著高于台湾一般人群和其他头颈癌患者。
研究设计与样本
- 基于台湾国民健康保险研究数据库2000至2011年数据的人群队列研究。
- 纳入14,893例鼻咽癌放疗患者和16,105例其他头颈癌放疗患者,均未行甲状腺切除术。
- 每例鼻咽癌患者按年龄、性别和索引年随机频数匹配4名无鼻咽癌个体。
- 采用竞争风险回归模型估计与鼻咽癌放疗相关的甲减风险比(HR)。
主要发现
- 鼻咽癌队列甲减风险显著高于匹配队列(调整HR=14.35,95%CI=11.85-17.37)。
- 鼻咽癌队列甲减风险显著高于其他头颈癌队列(调整HR=2.06,95%CI=1.69-2.52)。
- 鼻咽癌患者甲减独立危险因素包括较年轻年龄、女性、较高城市化水平、自身免疫病和接受化疗。
临床怎么用
- 鼻咽癌幸存者放疗后应定期进行临床和血清甲状腺功能检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This study aimed to assess the incidence and risk of hypothyroidism among patients with nasopharyngeal carcinoma (NPC) after radiation therapy (RT). MATERIAL AND METHODS: We identified 14,893 NPC patients and 16,105 other head and neck cancer (HNC) patients treated with RT without thyroidectomy from the National Health Insurance Research Database in Taiwan between 2000 and 2011. Each NPC patient was randomly frequency-matched with four individuals without NPC by age, sex, and index year. Competing-risk regression models were used to estimate hazard ratios (HRs) of hypothyroidism requiring thyroxin associated with NPC after RT. RESULTS: The risk of developing hypothyroidism was significantly higher in the NPC cohort than in the matched cohort (adjusted HR=14.35, 95% CI=11.85-17.37) and the HNC cohort (adjusted HR=2.06, 95% CI=1.69-2.52). Independent risk factors for hypothyroidism among NPC patients included younger age, female sex, higher urbanization level, autoimmune disease, and receipt of chemotherapy. CONCLUSION: The risk of hypothyroidism requiring thyroxin was significantly higher in NPC patients after RT than in the general Taiwanese population and HNC patients. Regular clinical and serum thyroid function tests are essential among NPC survivors after RT.
引用
- Fan CY, Lin CS, Chao HL, et al. Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study. Radiother Oncol. 2017. PMID: 28532605. doi:10.1016/j.radonc.2017.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。